HPV Testing: Promise and Challenges
ثبت نشده
چکیده
most common sexually transmitted infections (STIs), is the primary cause of cervical cancer. HPV infection is a necessary but not sufficient precursor to cervical cancer. While the cumulative lifetime incidence of acquiring HPV is 70 to 80 percent in many countries, the vast majority of women with HPV infection will not develop cancer (see PATH’s fact sheet, Natural History of Cervical Cancer). 2,3 Worldwide, interest is growing in the potential uses for HPV DNA testing in cervical cancer prevention programs (see Table 1). HPV testing indicates whether a woman is infected with high-risk HPV types and thus at increased risk of cervical cancer. The test’s relatively high sensitivity for detecting high-grade squamous intraepithelial lesions (HSIL) makes it particularly appealing. HPV Testing: Promise and Challenges
منابع مشابه
Pnm-17: Cost Effectiveness of Human Papillomavirus Testing in Cervical Cancer Diagnosis
Background: Epidemiological studies are shown robust association between human papillomavirus (HPV) and cervical cancer. From 1990 HPV was known as a necessary but insufficient cause of cervical invasive cancer. The purpose of this study was to evaluate the cost effectiveness of HPV test in cervical cancer screening. Materials and Methods: This is a systematic review article; the newest scienti...
متن کاملChapter 29: Knowledge gaps and priorities for research on prevention of HPV infection and cervical cancer.
The recognition that human papillomavirus (HPV) infection is the necessary cause of cervical cancer brought new prevention paradigms in screening and HPV immunization. We now face many questions about how to implement an ambitious evidence-based agenda for cervical cancer prevention. Much is known about the epidemiology and natural history of HPV infection but several key variables remain to be...
متن کاملRe: Human papillomavirus testing in the prevention of cervical cancer.
Strong evidence now supports the adoption of cervical cancer prevention strategies that explicitly focus on persistent infection with the causal agent, human papillomavirus (HPV). To inform an evidence-based transition to a new public health approach for cervical cancer screening, we summarize the natural history and cervical carcinogenicity of HPV and discuss the promise and uncertainties of c...
متن کاملSecond-generation prophylactic HPV vaccines: successes and challenges.
The role of HPV as the causative factor in cervical cancer has led to the development of the HPV vaccines Gardasil and Cervarix. These vaccines effectively protect against two HPV types associated with 70% of cervical cancer cases. Despite this success, researchers continue to develop second-generation HPV vaccines to protect against more HPV types and allow increased uptake in developing count...
متن کامل